パーキンソン病における脳深部刺激療法市場：製品別、エンドユーザー別-2025-2030年の世界予測

パーキンソン病における脳深部刺激療法市場は、2023年に10億7,000万米ドルと評価され、2024年には12億3,000万米ドルに達すると予測され、CAGR 15.40％で成長し、2030年には29億3,000万米ドルに達すると予測されています。

脳深部刺激療法（DBS）は、脳の特定部位に電極を埋め込む医療処置であり、主にパーキンソン病（PD）の運動症状（振戦、硬直、ジスキネジアなど）の管理に用いられます。DBSの必要性は、薬物療法の限界、特に薬物療法の有効性が低下するPDの進行期から生じています。DBSの主な用途は、病院や専門クリニックの神経内科や神経外科です。最終用途の範囲は、従来の治療で十分な効果が得られず、生活の質の向上を求める患者にまで及ぶ。市場成長の主な原動力は、人口の高齢化によるPDの有病率の増加と、外科手術の合理化とデバイス機能の強化を実現した神経技術の進歩です。主な成長要因としては、MRI対応DBSシステムなどの継続的な技術革新や、安全性と有効性に関する肯定的な長期データによる受容の拡大が挙げられます。DBSの普及はまだ低いがPDの有病率が上昇している新興国市場への進出や、リアルタイム調整を提供するクローズドループ・システムなどの次世代技術の開発に潜在的なビジネスチャンスがあります。企業への提言としては、研究開発への投資による機器の小型化とバッテリー寿命の延長の革新が挙げられ、これにより患者の快適性とコンプライアンスが向上します。しかし、DBS治療には高額な費用がかかること、認知度が低いこと、高度に熟練した手術チームが必要であることなど、市場の成長には限界があります。さらに、患者の選択基準や倫理的懸念に関する継続的な議論が市場の課題となっています。成長機会を活用するために、企業はヘルスケア機関や保険業者との提携を模索することで、コストとアクセシビリティの問題への対応に注力すべきです。DBSとデジタルヘルスプラットフォームの統合による遠隔モニタリングや、精神疾患などPD以外の分野への応用を模索することで、DBSの応用と収益の多様化に向けて新たなフロンティアを切り開くことなどが、イノベーションに最適な分野です。

市場力学：急速に進化するパーキンソン病における脳深部刺激療法市場の主要市場インサイトを公開

パーキンソン病における脳深部刺激療法市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 神経疾患の増加
  • 急速な高齢化による神経疾患のリスクと有病率の増加
  • 低侵襲手術の人気の高まり
• 市場抑制要因
  • 複雑な規制の枠組み
• 市場機会
  • 機器の技術進歩の増加
  • 神経学的研究開発の急増
• 市場の課題
  • 脳深部刺激手術の合併症

ポーターの5つの力：パーキンソン病における脳深部刺激療法市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：パーキンソン病における脳深部刺激療法市場における外部からの影響の把握

外部マクロ環境要因は、パーキンソン病における脳深部刺激療法市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析パーキンソン病における脳深部刺激療法市場における競合情勢の把握

パーキンソン病における脳深部刺激療法市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスパーキンソン病における脳深部刺激療法市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、パーキンソン病における脳深部刺激療法市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨パーキンソン病における脳深部刺激療法市場における成功への道筋を描く

パーキンソン病における脳深部刺激療法市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 神経疾患の発生率の増加
    • 急速に高齢化が進み、神経疾患のリスクと有病率が高くなっている
    • 低侵襲手術の人気の高まり
  • 抑制要因
    • 複雑な規制枠組み
  • 機会
    • デバイスの技術進歩の加速
    • 神経学の研究開発の急増
  • 課題
    • 脳深部刺激手術の合併症
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 パーキンソン病における脳深部刺激療法市場：製品別

• デュアルチャネル
• シングルチャンネル

第7章 パーキンソン病における脳深部刺激療法市場：エンドユーザー別

• 外来手術センター
• 病院
• 神経科クリニック
• 研究センター

第8章 南北アメリカのパーキンソン病における脳深部刺激療法市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域のパーキンソン病における脳深部刺激療法市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのパーキンソン病における脳深部刺激療法市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 1. Abbott Laboratories
• 2. Aleva Neurotherapeutics SA
• 3. Beijing Pins Medical Co.,Ltd.
• 4. Boston Scientific Corporation
• 5. Functional Neuromodulation Ltd.
• 6. General Electric Co.
• 7. Medtronic PLC
• 8. MicroTransponder Inc.
• 9. Neuronetics Inc.
• 10. NeuroPace Inc.
• 11. NeuroSigma, Inc.
• 12. Nexstim Oy
• 13. Renishaw PLC
• 14. Siemens AG
• 15. St. Jude Medical, Inc.
• 16. Synapse Biomedical Inc.

LIST OF FIGURES

• FIGURE 1. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET RESEARCH PROCESS
• FIGURE 2. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET DYNAMICS
• TABLE 7. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY DUAL CHANNEL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY SINGLE CHANNEL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY NEUROLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 18. ARGENTINA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 19. ARGENTINA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 20. BRAZIL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 21. BRAZIL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 22. CANADA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 23. CANADA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 24. MEXICO DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 25. MEXICO DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 32. AUSTRALIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. AUSTRALIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. CHINA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. CHINA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. INDIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. INDIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. INDONESIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. INDONESIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. JAPAN DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. JAPAN DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. MALAYSIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. MALAYSIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. PHILIPPINES DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. PHILIPPINES DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. SINGAPORE DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. SINGAPORE DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. SOUTH KOREA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. SOUTH KOREA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. TAIWAN DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. TAIWAN DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. THAILAND DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. THAILAND DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. VIETNAM DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. VIETNAM DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 59. DENMARK DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. DENMARK DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. EGYPT DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. EGYPT DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. FINLAND DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. FINLAND DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. FRANCE DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. FRANCE DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. GERMANY DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. GERMANY DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. ISRAEL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. ISRAEL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. ITALY DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. ITALY DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. NETHERLANDS DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. NETHERLANDS DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. NIGERIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. NIGERIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. NORWAY DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. NORWAY DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. POLAND DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. POLAND DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. QATAR DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. QATAR DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. RUSSIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. RUSSIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. SAUDI ARABIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. SAUDI ARABIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH AFRICA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH AFRICA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. SPAIN DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. SPAIN DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. SWEDEN DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. SWEDEN DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. SWITZERLAND DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. SWITZERLAND DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. TURKEY DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. TURKEY DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. UNITED ARAB EMIRATES DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. UNITED ARAB EMIRATES DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. UNITED KINGDOM DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. UNITED KINGDOM DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 102. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET, FPNV POSITIONING MATRIX, 2023

The Deep Brain Stimulation in Parkinson's Disease Market was valued at USD 1.07 billion in 2023, expected to reach USD 1.23 billion in 2024, and is projected to grow at a CAGR of 15.40%, to USD 2.93 billion by 2030.

Deep brain stimulation (DBS) is a medical procedure that involves implanting electrodes within specific brain areas; it is primarily used to manage the motor symptoms of Parkinson's Disease (PD), such as tremors, rigidity, and dyskinesia. The necessity of DBS arises from the limitations of pharmacologic treatments, particularly in advanced PD stages where medication efficacy wanes. Its primary applications span neurology and neurosurgery departments in hospitals and specialized clinics. The end-use scope extends to patients who do not respond adequately to conventional treatments and seek improved quality of life. Market growth is largely driven by the increasing prevalence of PD due to an aging population and advancements in neurotechnology that have streamlined surgical procedures and enhanced device capabilities. Key growth factors include continuous technological innovation, such as MRI-compatible DBS systems, and increasing acceptance owing to positive long-term data on safety and efficacy. Potential opportunities lie in expanding into emerging markets where DBS adoption remains low but PD prevalence is rising, and in developing next-generation technologies like closed-loop systems that offer real-time adjustments. Recommendations for businesses would include investing in R&D to innovate on device miniaturization and battery life extension, thus enhancing patient comfort and compliance. However, market growth faces limitations such as the high cost of DBS procedures, lack of awareness, and the need for highly skilled surgical teams, which may hinder implementation in resource-constrained settings. Additionally, the market is challenged by ongoing debates on patient selection criteria and ethical concerns. To leverage growth opportunities, companies should focus on addressing cost and accessibility issues by exploring partnerships with healthcare institutions and insurance providers. The best areas for innovation include the integration of DBS with digital health platforms for remote monitoring and exploring non-PD applications such as psychiatric disorders, opening new frontiers for DBS application and revenue diversification.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Deep Brain Stimulation in Parkinson's Disease Market

The Deep Brain Stimulation in Parkinson's Disease Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing incidences of neurological diseases
  • Rapidly aging population, leading to risk and high prevalence of neurological disorders
  • Rising popularity of minimally invasive procedures
• Market Restraints
  • Complex regulatory framework
• Market Opportunities
  • Increasing technological advancement in devices
  • Surge in neurological R&D
• Market Challenges
  • Complications of deep brain stimulation surgery

Porter's Five Forces: A Strategic Tool for Navigating the Deep Brain Stimulation in Parkinson's Disease Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Deep Brain Stimulation in Parkinson's Disease Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Deep Brain Stimulation in Parkinson's Disease Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Deep Brain Stimulation in Parkinson's Disease Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Deep Brain Stimulation in Parkinson's Disease Market

A detailed market share analysis in the Deep Brain Stimulation in Parkinson's Disease Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Deep Brain Stimulation in Parkinson's Disease Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Deep Brain Stimulation in Parkinson's Disease Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Deep Brain Stimulation in Parkinson's Disease Market

A strategic analysis of the Deep Brain Stimulation in Parkinson's Disease Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Deep Brain Stimulation in Parkinson's Disease Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aleva Neurotherapeutics SA, Beijing Pins Medical Co.,Ltd., Boston Scientific Corporation, Functional Neuromodulation Ltd., General Electric Co., Medtronic PLC, MicroTransponder Inc., Neuronetics Inc., NeuroPace Inc., NeuroSigma, Inc., Nexstim Oy, Renishaw PLC, Siemens AG, St. Jude Medical, Inc., and Synapse Biomedical Inc..

Market Segmentation & Coverage

This research report categorizes the Deep Brain Stimulation in Parkinson's Disease Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Dual Channel and Single Channel.
• Based on End-User, market is studied across Ambulatory Surgical Centers, Hospitals, Neurology Clinics, and Research Centers.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidences of neurological diseases
    • 5.1.1.2. Rapidly aging population, leading to risk and high prevalence of neurological disorders
    • 5.1.1.3. Rising popularity of minimally invasive procedures
  • 5.1.2. Restraints
    • 5.1.2.1. Complex regulatory framework
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing technological advancement in devices
    • 5.1.3.2. Surge in neurological R&D
  • 5.1.4. Challenges
    • 5.1.4.1. Complications of deep brain stimulation surgery
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Deep Brain Stimulation in Parkinson's Disease Market, by Product

• 6.1. Introduction
• 6.2. Dual Channel
• 6.3. Single Channel

7. Deep Brain Stimulation in Parkinson's Disease Market, by End-User

• 7.1. Introduction
• 7.2. Ambulatory Surgical Centers
• 7.3. Hospitals
• 7.4. Neurology Clinics
• 7.5. Research Centers

8. Americas Deep Brain Stimulation in Parkinson's Disease Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Aleva Neurotherapeutics SA
• 3. Beijing Pins Medical Co.,Ltd.
• 4. Boston Scientific Corporation
• 5. Functional Neuromodulation Ltd.
• 6. General Electric Co.
• 7. Medtronic PLC
• 8. MicroTransponder Inc.
• 9. Neuronetics Inc.
• 10. NeuroPace Inc.
• 11. NeuroSigma, Inc.
• 12. Nexstim Oy
• 13. Renishaw PLC
• 14. Siemens AG
• 15. St. Jude Medical, Inc.
• 16. Synapse Biomedical Inc.